Picture of BioPorto A/S logo

BIOPOR BioPorto A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Bioporto Q4 Adj EBITDA Loss Down At 17.9 Mln

March 30 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * BIOPORTO ANNOUNCES ANNUAL RESULTS FOR THE YEAR ENDED
DECEMBER
31, 2022
    * Q4 ADJUSTED EBITDA LOSS OF DKK 17.9 MILLION
    * BECAUSE OF GROUP’S NEED FOR CAPITAL TO IMPLEMENT ITS
STRATEGIC
INITIATIVES, ACHIEVE HIGHER SALES, NO DIVIDEND IS EXPECTED TO BE
PAID IN 2023
    * OUTLOOK 2023: ADJUSTED EBITDA LOSS ABOUT DKK (60) TO (65)
MILLION
    * OUTLOOK 2023: REVENUE AT ABOUT DKK 30 TO 33 MILLION
    * PERFORMANCE AND GUIDANCE FOR 2023 ARE DEPENDENT ON
CONTINUED
RESOLUTION OF COVID-19 PANDEMIC

Source text for Eikon:  ID:nGNES0lSQ 
Further company coverage:  BIOPOR.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on BioPorto A/S

See all news